Your browser doesn't support javascript.
loading
Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada.
Reece, Donna E; Masih-Khan, Esther; Atenafu, Ehetu G; Jimenez-Zepeda, Victor H; McCurdy, Arleigh; Song, Kevin; LeBlanc, Richard; Sebag, Michael; White, Darrell; Cherniawsky, Hannah; Reiman, Anthony; Stakiw, Julie; Louzada, Martha L; Kotb, Rami; Aslam, Muhammad; Gul, Engin; Venner, Christopher P.
Afiliación
  • Reece DE; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Masih-Khan E; Canadian Myeloma Research Group, Toronto, ON, Canada.
  • Atenafu EG; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Jimenez-Zepeda VH; Canadian Myeloma Research Group, Toronto, ON, Canada.
  • McCurdy A; Canadian Myeloma Research Group, Toronto, ON, Canada.
  • Song K; University of Calgary, Arnie Charbonneau Cancer Institute, Calgary, AB, Canada.
  • LeBlanc R; The Ottawa Hospital, Ottawa, ON, Canada.
  • Sebag M; BC Cancer, Vancouver General Hospital, Vancouver, BC, Canada.
  • White D; Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, QC, Canada.
  • Cherniawsky H; Departments of Medicine and Oncology, Division of Hematology, McGill University, Montreal, QC, Canada.
  • Reiman A; Dalhousie University and QEII Health Sciences Centre, Halifax, NS, Canada.
  • Stakiw J; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
  • Louzada ML; Department of Oncology, Saint John Regional Hospital, Saint John, NB, Canada.
  • Kotb R; University of Saskatchewan, Saskatoon, SK, Canada.
  • Aslam M; London Regional Cancer Center, London, ON, Canada.
  • Gul E; Cancer Care Manitoba, Winnipeg, MB, Canada.
  • Venner CP; Allan Blair Cancer Centre, Regina, SK, Canada.
Eur J Haematol ; 107(4): 416-427, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34129703

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Lenalidomida / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Lenalidomida / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article